The Chronic Obstructive Pulmonary Disease (COPD)-Bronchiectasis Overlap Syndrome: Does My COPD Patient Have Bronchiectasis on Computed Tomography? "Frankly, My Dear, I Don't Give a Damn!"

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2023 Oct 5

PMID 37796579

Authors

Mark L Metersky

Mark T Dransfield

Affiliations

Soon will be listed here.

Citing Articles

Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications.

Alam M, Mangapuram P, Fredrick F, Singh B, Singla A, Kumar A Ther Adv Pulm Crit Care Med. 2024; 19:29768675241300808.

PMID: 39655338 PMC: 11626662. DOI: 10.1177/29768675241300808.

References

Dicker A, Crichton M, Pumphrey E, Cassidy A, Suarez-Cuartin G, Sibila O . Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2017; 141(1):117-127. PMC: 5751731. DOI: 10.1016/j.jaci.2017.04.022. View

Hao W, Li M, Zhang Y, Zhang C, Xue Y . Expressions of MMP-12, TIMP-4, and Neutrophil Elastase in PBMCs and Exhaled Breath Condensate in Patients with COPD and Their Relationships with Disease Severity and Acute Exacerbations. J Immunol Res. 2019; 2019:7142438. PMC: 6501161. DOI: 10.1155/2019/7142438. View

Sobala R, Soyza A . Bronchiectasis and Chronic Obstructive Pulmonary Disease Overlap Syndrome. Clin Chest Med. 2022; 43(1):61-70. DOI: 10.1016/j.ccm.2021.11.005. View

Chalmers J, Moffitt K, Suarez-Cuartin G, Sibila O, Finch S, Furrie E . Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis. Am J Respir Crit Care Med. 2016; 195(10):1384-1393. PMC: 5443898. DOI: 10.1164/rccm.201605-1027OC. View

Keir H, Shoemark A, Dicker A, Perea L, Pollock J, Giam Y . Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. Lancet Respir Med. 2021; 9(8):873-884. DOI: 10.1016/S2213-2600(20)30504-X. View

Carter R, Ungurs M, Mumford R, Stockley R . Aα-Val360: a marker of neutrophil elastase and COPD disease activity. Eur Respir J. 2012; 41(1):31-8. DOI: 10.1183/09031936.00197411. View

Martinez-Garcia M, de la Rosa-Carrillo D, Soler-Cataluna J, Catalan-Serra P, Ballester M, Roca Vanaclocha Y . Bronchial Infection and Temporal Evolution of Bronchiectasis in Patients With Chronic Obstructive Pulmonary Disease. Clin Infect Dis. 2020; 72(3):403-410. DOI: 10.1093/cid/ciaa069. View

Diaz A, Orejas J, Grumley S, Nath H, Wang W, Dolliver W . Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease. JAMA. 2023; 329(21):1832-1839. PMC: 10201404. DOI: 10.1001/jama.2023.2065. View

Chalmers J, Aliberti S, Filonenko A, Shteinberg M, Goeminne P, Hill A . Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis. Am J Respir Crit Care Med. 2018; 197(11):1410-1420. DOI: 10.1164/rccm.201711-2202OC. View

10.

Chalmers J, Boersma W, Lonergan M, Jayaram L, Crichton M, Karalus N . Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respir Med. 2019; 7(10):845-854. DOI: 10.1016/S2213-2600(19)30191-2. View

11.

Chalmers J, Haworth C, Metersky M, Loebinger M, Blasi F, Sibila O . Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. N Engl J Med. 2020; 383(22):2127-2137. DOI: 10.1056/NEJMoa2021713. View

12.

Metersky M, Chalmers J . Bronchiectasis insanity: Doing the same thing over and over again and expecting different results?. F1000Res. 2019; 8. PMC: 6426099. DOI: 10.12688/f1000research.17295.1. View

13.

Sibila O, Laserna E, Shoemark A, Keir H, Finch S, Rodrigo-Troyano A . Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis. Am J Respir Crit Care Med. 2019; 200(1):33-41. DOI: 10.1164/rccm.201809-1651OC. View

14.

Zhang M, Li Q, Zhang X, Ding X, Zhu D, Zhou X . Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis. 2010; 29(12):1487-93. DOI: 10.1007/s10096-010-1027-7. View

15.

Lynch D, Newell J, Hale V, Dyer D, Corkery K, Fox N . Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. AJR Am J Roentgenol. 1999; 173(1):53-8. DOI: 10.2214/ajr.173.1.10397099. View

16.

Butler A, Walton G, Sapey E . Neutrophilic Inflammation in the Pathogenesis of Chronic Obstructive Pulmonary Disease. COPD. 2018; 15(4):392-404. DOI: 10.1080/15412555.2018.1476475. View

17.

Wilkinson T, Patel I, Wilks M, Donaldson G, Wedzicha J . Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 167(8):1090-5. DOI: 10.1164/rccm.200210-1179OC. View

18.

Eklof J, Sorensen R, Ingebrigtsen T, Sivapalan P, Achir I, Boel J . Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients. Clin Microbiol Infect. 2019; 26(2):227-234. DOI: 10.1016/j.cmi.2019.06.011. View

19.

Garcia-Vidal C, Almagro P, Romani V, Rodriguez-Carballeira M, Cuchi E, Canales L . Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J. 2009; 34(5):1072-8. DOI: 10.1183/09031936.00003309. View

20.

Metersky M, Barker A . The Pathogenesis of Bronchiectasis. Clin Chest Med. 2022; 43(1):35-46. DOI: 10.1016/j.ccm.2021.11.003. View